Practical issues in relation to clinical trials in children in low-income countries: experience from the front line

Elizabeth Molyneux1, Don Mathanga, Desiree Witte

  • 1College of Medicine, Paediatric Department, Blantyre, Malawi. emmolyneux@gmail.com

Insights

Conducting ethical and high-quality clinical trials in children in resource-poor settings is crucial. Maximizing benefits for participants and host countries while mitigating risks is key.

Area of Science:

  • Pediatric Research
  • Global Health Equity
  • Evidence-Based Practice

Background:

  • Clinical trials in children are vital for informing local health policies in resource-poor environments.
  • Ensuring research relevance and quality is paramount for effective healthcare.
  • Ethical considerations are fundamental in pediatric research conducted in vulnerable populations.

Purpose of the Study:

  • To highlight the necessity of clinical trials in children within resource-limited settings.
  • To emphasize the importance of ethical, appropriate, relevant, and high-quality research.
  • To outline the potential benefits and challenges of conducting such trials.

Main Methods:

  • This study is a conceptual analysis and ethical review of clinical trial principles.
  • It synthesizes existing literature on research ethics and global health.
  • No primary data collection was performed; it relies on ethical frameworks and best practices.

Main Results:

  • Clinical trials must be designed to be ethically sound and scientifically rigorous.
  • Research should aim to benefit child participants, research staff, and host institutions.
  • Potential pitfalls in resource-poor environments require careful consideration and mitigation strategies.

Conclusions:

  • Ethical and high-quality clinical trials in children are essential for evidence-based healthcare in resource-poor settings.
  • Maximizing benefits for all stakeholders, including participants and host countries, should be a primary goal.
  • Careful planning is required to navigate the complexities and avoid ethical and practical pitfalls.

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...